Stock YS YS BIOPHARMA CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus YS Biopharma Co., Ltd.

Equities

YS

KYG9845F1090

Market Closed - Nasdaq
Other stock markets
 21:30:01 17/05/2024 BST 		5-day change 1st Jan Change
0.9779 USD +2.93% Intraday chart for YS Biopharma Co., Ltd. +0.81% +91.37%
04-19 YS Biopharma Co., Ltd. Reports Earnings Results for the Nine Months Ended December 31, 2023 CI
04-18 YS Biopharma Receives Clinical Trial Approval for Potential Hepatitis B Treatment MT

Evolution of the average Target Price on YS Biopharma Co., Ltd.

Price target over the last 5 years

History of analyst recommendation changes

137a94a8f55f057e10371fb.Nn1jhdJPx3jQnP6zTbiakYF9oxwYJbUgotJQOJDw6QA.VBZT9rR5ize4qMvjEu7r6NYw7khaaYFm27oUDffEmFdDKTHXlXqwAaiuqw~36b888d54627d3ea62d5b010cef75455

Analyst Recommendations on YS Biopharma Co., Ltd.

Noble Capital Initiates YS Biopharma With Outperform Rating, $5.25 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
7.062 CNY
Average target price
29.98 CNY
Spread / Average Target
+324.53%
High Price Target
37.51 CNY
Spread / Highest target
+431.09%
Low Price Target
22.46 CNY
Spread / Lowest Target
+217.97%

Consensus detail

Consensus revision (last 18 months)

Analysts covering YS Biopharma Co., Ltd.

Noble Capital

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. YS Stock
  4. Consensus YS Biopharma Co., Ltd.